reports
Advantage Solutions Reports Fourth Quarter and Full Year 2025 Results
Advantage Solutions Reports Fourth Quarter and Full Year 2025 Results Strong cash flow performance resulted in ending the quarter with $241 million of cash, up $40 million sequentially Completion of non-core divestitures, planned debt refinancing and upcoming reverse stock split Expect flat to up low-single digit revenue growth in 2026, Adjusted EBITDA flat to down mid-single digits ST. LOUIS, March 03, 2026 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ: ADV) (“Advantage,” “Advantage Solutions,” the “Company,” “we,” or “our”), a leading business solutions provider to ...
Advantage Solutions Appoints Thomas Turner and Frank Yao to Board of D...
Advantage Solutions Appoints Thomas Turner and Frank Yao to Board of Directors ST. LOUIS, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ: ADV) announced the appointments of Thomas Turner and Xiaofeng "Frank" Yao to its Board of Directors, effective as of February 20, 2026. About Thomas Turner Turner currently serves as Senior Managing Director at CVC Capital Partners (U.S.) Inc., where he has been a member of the Capital Markets team since September 2022. Prior to CVC, Turner held Managing Director roles at Apollo Global Management, Inc. and Bank of America Merrill L...
Advantage Solutions Inc. Announces Early Results of Previously Announc...
Advantage Solutions Inc. Announces Early Results of Previously Announced Exchange Offer and Consent Solicitation Holders of greater than 99% of the aggregate principal amount of the Existing Notes have already tendered and delivered their consents. Holders of greater than 99% of the aggregate principal amount of the Existing Term Loans have already agreed to participate in the Term Loans Transactions. ST. LOUIS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ: ADV) (“Advantage Solutions”), a leading provider of business solutions to consumer goods manufacturers and re...
Beyond Air® Comments on Landmark Independent Review Article Highlighti...
Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections GARDEN CITY, N.Y., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today commented on the publication of an independent review article providing the most comprehensive overview to date of high‑d...
Advantage Solutions Announces Date for its Fourth Quarter and Full Yea...
Advantage Solutions Announces Date for its Fourth Quarter and Full Year 2025 Financial Results and Conference Call ST. LOUIS, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ GS: ADV), announced today that it will release financial results for the fourth quarter and full year at 7 a.m. EDT on March 3, 2026, followed by a conference call at 8:30 a.m. EDT on the same day. The conference call can be accessed live by dialing 1-800-715-9871 for U.S. callers or 1-646-307-1963 for international callers. The conference ID is 5720569. Approximately three hours after the call, a ...
- Dave Nicoski
- Ross LaDuke
O5Q OWENS CORNING
WHR WHIRLPOOL CORPORATION
CBT CABOT CORPORATION
LNG CHENIERE ENERGY INC.
VC VISTEON CORPORATION
SM SM ENERGY COMPANY
EVEREST RE GROUP LTD.
NWL NEWELL BRANDS INC
LNTH LANTHEUS HOLDINGS INC
KRO KRONOS WORLDWIDE INC.
IOSP INNOSPEC INC.
HY HYSTER-YALE MATERIALS HANDLING INC. CLASS A
GLPI GAMING AND LEISURE PROPERTIES INC.
DECK DECKERS OUTDOOR CORPORATION
CHH CHOICE HOTELS INTERNATIONAL INC.
BCC BOISE CASCADE CO.
APD AIR PRODUCTS AND CHEMICALS INC.
CHE CHEMED CORPORATION
COLM COLUMBIA SPORTSWEAR COMPANY
TNC TENNANT COMPANY
WSO WATSCO INC.
BXC BLUELINX HOLDINGS
FTV FORTIVE CORP.
BCBP BCB BANCORP INC.
BBWI BATH & BODY WORKS INC
AESI NEW ATLAS HOLDCO INC
BGC BGC GROUP INC
Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Pr...
Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update Increased revenue by 105% year-over-year (YoY) to $2.2 million in fiscal Q3 Maintain fiscal year 2026 revenue guidance of $8-10 million $22.3 million pro forma cash, cash equivalents, restricted cash and marketable securities, including net proceeds from recent PIPE transaction, expected to provide runway into calendar 2027 Signed binding letter of intent for XTL Biopharmaceuticals to acquire 85% of Beyond Air's subsidiary NeuroNOS; Beyond Air to receive up to $32.5 million from the combinatio...
Advantage Solutions Strengthens Senior Leadership to Accelerate Growth...
Advantage Solutions Strengthens Senior Leadership to Accelerate Growth Strategy New appointments and expanded roles position company for sustained performance ST. LOUIS, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ: ADV), a leading provider of business solutions to consumer goods manufacturers and retailers, today announced changes to its executive leadership team designed to accelerate its growth strategy. Key leadership changes include: Bob Hardester appointed Chief Information Officer (effective March 2, 2026)Jo O’Hazo promoted to Deputy CIO & Chief Data Offic...
Beyond Cancer Abstract Featuring Phase 1 Data on Intratumoral Ultra-Hi...
Beyond Cancer Abstract Featuring Phase 1 Data on Intratumoral Ultra-High Concentration Nitric Oxide (UNO) in Solid Tumor Metastases to be Presented at the AACR Annual Meeting 2026 GARDEN CITY, N.Y., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd., a clinical stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors and subsidiary of Beyond Air, Inc. (NASDAQ: XAIR), today announced being selected to present an abstract featuring data from the Phase 1 trial of intratumoral UNO in solid tumor metastases at the American A...
Heartland Express, Inc. Reports Fourth Quarter and Annual Financial Re...
Heartland Express, Inc. Reports Fourth Quarter and Annual Financial Results NORTH LIBERTY, Iowa, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Heartland Express, Inc. (Nasdaq: HTLD) announced today financial results for the quarter and year ended December 31, 2025. Three months ended December 31, 2025: Operating Revenue of $179.4 million,Net Loss of $19.4 million and Basic Loss per Share of $0.25,8.3% Operating Cash Flows as a percentage of Operating Revenue,Operating Ratio of 112.7% (which includes the impacts of a non-cash trade name impairment of $19.0 million) and 101.6% Non-GAAP Adjusted Opera...
Beyond Air to Participate in Two Upcoming Healthcare Investor Conferen...
Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences GARDEN CITY, N.Y., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide to improve the lives of patients, today announced that Steve Lisi, Chairman & Chief Executive Officer of Beyond Air, will participate in the 13th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held February 9th to 11th in Snowbird, UT and the Noble Cap...
Beyond Air Schedules Third Fiscal Quarter 2026 Financial Results Confe...
Beyond Air Schedules Third Fiscal Quarter 2026 Financial Results Conference Call and Webcast GARDEN CITY, N.Y., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced that it will report financial results for its third fiscal quarter ended December 31, 2025 on Friday, February 13, 2026. The Company's management team is scheduled to host a conference call and webcast at 8:00 am East...
Beyond Air Announces $5.0 Million Private Placement Priced At-the-Mark...
Beyond Air Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules GARDEN CITY, N.Y., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide to improve the lives of patients, today announced that it entered into a securities purchase agreement with an institutional investor to issue and sell, in a private placement priced at-the-market under Nasdaq rules, 3,930,818 shares of common stock (or pre-funded warrants...
XTL Biopharmaceuticals Acquires 85% of Beyond Air’s Subsidiary NeuroNO...
XTL Biopharmaceuticals Acquires 85% of Beyond Air’s Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership Unmatched scientific firepower: Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in 31 U.S. children now affected, zero FDA-approved disease-modifying therapies exist FDA Orphan Drug designations secured for autism-related Phelan-McDermid Syndrome (PMS) and Glioblastoma Platform targets the core biology of autism, not just symptomatic relief Beyond Air (NASDAQ: XAIR), majorit...
Beyond Air® Appoints Dan Moorhead as Chief Financial Officer
Beyond Air® Appoints Dan Moorhead as Chief Financial Officer GARDEN CITY, N.Y., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced the appointment of Dan Moorhead as Chief Financial Officer, effective January 5, 2026. Duke Dewrell, the Company's Controller, who had assumed CFO responsibilities at the Company on an interim basis in November 2025, will resume his prior role as of...
Beyond Air® Signs New International LungFit PH® Distribution Agreement...
Beyond Air® Signs New International LungFit PH® Distribution Agreements, Most Notably in Germany and Brazil Distribution network coverage expanded to a total of 39 countries GARDEN CITY, N.Y., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced the recent signing of several key international distribution agreements for LungFit® PH, expanding its network to include Germany, Bra...
Heartland Express, Inc. Declares Regular Quarterly Dividend
Heartland Express, Inc. Declares Regular Quarterly Dividend NORTH LIBERTY, Iowa, Dec. 16, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Heartland Express, Inc. (Nasdaq: HTLD) announced today the declaration of a regular quarterly cash dividend. The $0.02 per share dividend will be paid on January 7, 2026, to shareholders of record at the close of business on December 26, 2025. We currently estimate that a total of $1.6 million will be paid on the Company's approximate seventy-eight million shares of common stock. This is the Company's ninetieth consecutive quarterly cash dividend. Wi...
Moody's Ratings affirms Zimmer Biomet's Baa2 senior unsecured rating; ...
Moody's Ratings (Moody's) affirmed the senior unsecured ratings of Zimmer Biomet Holdings, Inc. ("Zimmer Biomet") at Baa2. The outlook is stable. The ratings affirmation reflects solid operating performance due to strong demand and operational improvements that have contributed to solid organic gr...
Heartland Express, Inc. Announces Integration of CFI’s U.S. Operations...
Heartland Express, Inc. Announces Integration of CFI’s U.S. Operations into Heartland Express NORTH LIBERTY, Iowa, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Heartland Express, Inc. (Nasdaq: HTLD) (the “Company”) announced today that the Company plans to integrate the U.S. operations of Contract Freighters, Inc. (“CFI”) into Heartland Express, effective December 31, 2025. The Company’s Chief Executive Officer, Mike Gerdin, commented, “We are excited to announce the integration and rebranding of the U.S. operations of CFI into Heartland Express, similar to several of our prior acquisitions. CFI ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.